Mark L Perry - Net Worth and Insider Trading
Mark L Perry Net Worth
The estimated net worth of Mark L Perry is at least $365 Million dollars as of 2024-11-13. Mark L Perry is the Director of NVIDIA Corp and owns about 1,386,120 shares of NVIDIA Corp (NVDA) stock worth over $206 Million. Mark L Perry is the EVP Operations of Gilead Sciences Inc and owns about 1,613,120 shares of Gilead Sciences Inc (GILD) stock worth over $152 Million. Mark L Perry is also the Director of MyoKardia Inc and owns about 25,408 shares of MyoKardia Inc (MYOK) stock worth over $6 Million. Besides these, Mark L Perry also holds Global Blood Therapeutics Inc (GBT) . Details can be seen in Mark L Perry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark L Perry has not made any transactions after 2024-02-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark L Perry
Mark L Perry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark L Perry owns 5 companies in total, including MyoKardia Inc (MYOK) , Global Blood Therapeutics Inc (GBT) , and NVIDIA Corp (NVDA) among others .
Click here to see the complete history of Mark L Perry’s form 4 insider trades.
Insider Ownership Summary of Mark L Perry
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MYOK | MyoKardia Inc | 2020-06-18 | director |
| GBT | Global Blood Therapeutics Inc | 2020-05-12 | director |
| NVDA | NVIDIA Corp | 2024-02-23 | director |
 | | 2003-10-13 | director |
| | 2004-02-03 | EVP Operations |
Mark L Perry Latest Holdings Summary
Mark L Perry currently owns a total of 4 stocks. Among these stocks, Mark L Perry owns 1,386,120 shares of NVIDIA Corp (NVDA) as of February 23, 2024, with a value of $206 Million and a weighting of 56.27%. Mark L Perry owns 1,613,120 shares of Gilead Sciences Inc (GILD) as of February 3, 2004, with a value of $152 Million and a weighting of 41.67%. Mark L Perry also owns 25,408 shares of MyoKardia Inc (MYOK) as of November 3, 2015, with a value of $6 Million and a weighting of 1.56%. The other 1 stocks Global Blood Therapeutics Inc (GBT) have a combined weighting of 0.5% among all his current holdings.
Latest Holdings of Mark L Perry
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVDA | NVIDIA Corp | 2024-02-23 | 1,386,120 | 148.29 | 205,547,735 |
| GILD | Gilead Sciences Inc | 2004-02-03 | 1,613,120 | 94.35 | 152,197,872 |
| MYOK | MyoKardia Inc | 2015-11-03 | 25,408 | 224.91 | 5,714,513 |
| GBT | Global Blood Therapeutics Inc | 2020-05-12 | 26,428 | 68.49 | 1,810,054 |
Holding Weightings of Mark L Perry
Mark L Perry Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark L Perry has made a total of 6 transactions in NVIDIA Corp (NVDA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in NVIDIA Corp is the sale of 150,000 shares on February 23, 2024, which brought Mark L Perry around $12 Million.
According to the SEC Form 4 filings, Mark L Perry has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 397,728 shares on February 3, 2004, which brought Mark L Perry around $3 Million.
According to the SEC Form 4 filings, Mark L Perry has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the acquisition of 5,000 shares on November 3, 2015, which cost Mark L Perry around $50,000.
More details on Mark L Perry's insider transactions can be found in the Insider Trading History of Mark L Perry table.Insider Trading History of Mark L Perry
- 1
Mark L Perry Trading Performance
GuruFocus tracks the stock performance after each of Mark L Perry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark L Perry is -14.67%. GuruFocus also compares Mark L Perry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark L Perry within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark L Perry's insider trading performs compared to the benchmark.
Performance of Mark L Perry
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.59 | | | | | |
| Relative Return to S&P 500(%) | 14.69 | | | | | |
Mark L Perry Ownership Network
Ownership Network List of Mark L Perry
Ownership Network Relation of Mark L Perry
Mark L Perry Owned Company Details
What does MyoKardia Inc do?
Who are the key executives at MyoKardia Inc?
Mark L Perry is the director of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .
MyoKardia Inc (MYOK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
MyoKardia Inc Insider Transactions
Mark L Perry Mailing Address
Above is the net worth, insider trading, and ownership report for Mark L Perry. You might contact Mark L Perry via mailing address: 176 West Blithedale Ave, Mill Valley Ca 94941.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
